Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages
- PMID: 20361208
- DOI: 10.1007/s00429-010-0246-0
Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages
Abstract
Recent cerebral blood flow (CBF) and glucose consumption (CMRglc) studies of Parkinson's disease (PD) revealed conflicting results. Using simulated data, we previously demonstrated that the often-reported subcortical hypermetabolism in PD could be explained as an artifact of biased global mean (GM) normalization, and that low-magnitude, extensive cortical hypometabolism is best detected by alternative data-driven normalization methods. Thus, we hypothesized that PD is characterized by extensive cortical hypometabolism but no concurrent widespread subcortical hypermetabolism and tested it on three independent samples of PD patients. We compared SPECT CBF images of 32 early-stage and 33 late-stage PD patients with that of 60 matched controls. We also compared PET FDG images from 23 late-stage PD patients with that of 13 controls. Three different normalization methods were compared: (1) GM normalization, (2) cerebellum normalization, (3) reference cluster normalization (Yakushev et al.). We employed standard voxel-based statistics (fMRIstat) and principal component analysis (SSM). Additionally, we performed a meta-analysis of all quantitative CBF and CMRglc studies in the literature to investigate whether the global mean (GM) values in PD are decreased. Voxel-based analysis with GM normalization and the SSM method performed similarly, i.e., both detected decreases in small cortical clusters and concomitant increases in extensive subcortical regions. Cerebellum normalization revealed more widespread cortical decreases but no subcortical increase. In all comparisons, the Yakushev method detected nearly identical patterns of very extensive cortical hypometabolism. Lastly, the meta-analyses demonstrated that global CBF and CMRglc values are decreased in PD. Based on the results, we conclude that PD most likely has widespread cortical hypometabolism, even at early disease stages. In contrast, extensive subcortical hypermetabolism is probably not a feature of PD.
Similar articles
-
Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease.Q J Nucl Med Mol Imaging. 2012 Jun;56(3):299-308. Q J Nucl Med Mol Imaging. 2012. PMID: 22695340 Free PMC article.
-
Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease.Neuroimage. 2009 Apr 1;45(2):249-57. doi: 10.1016/j.neuroimage.2008.07.042. Epub 2008 Jul 31. Neuroimage. 2009. PMID: 18718541
-
Glucose metabolism in small subcortical structures in Parkinson's disease.Acta Neurol Scand. 2012 May;125(5):303-10. doi: 10.1111/j.1600-0404.2011.01556.x. Epub 2011 Jun 21. Acta Neurol Scand. 2012. PMID: 21692755 Clinical Trial.
-
Perfusion and metabolism imaging studies in Parkinson's disease.Dan Med J. 2012 Jun;59(6):B4466. Dan Med J. 2012. PMID: 22677251 Review.
-
Molecular imaging and the neuropathologies of Parkinson's disease.Curr Top Behav Neurosci. 2012;11:117-48. doi: 10.1007/7854_2011_165. Curr Top Behav Neurosci. 2012. PMID: 22034053 Review.
Cited by
-
Validation of dynamic [18F]FE-PE2I PET for estimation of relative regional cerebral blood flow: a comparison with [15O]H2O PET.EJNMMI Res. 2022 Nov 17;12(1):72. doi: 10.1186/s13550-022-00941-8. EJNMMI Res. 2022. PMID: 36394638 Free PMC article.
-
In vivo X-Nuclear MRS Imaging Methods for Quantitative Assessment of Neuroenergetic Biomarkers in Studying Brain Function and Aging.Front Aging Neurosci. 2018 Nov 27;10:394. doi: 10.3389/fnagi.2018.00394. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30538629 Free PMC article.
-
Computational prediction of changes in brain metabolic fluxes during Parkinson's disease from mRNA expression.PLoS One. 2018 Sep 12;13(9):e0203687. doi: 10.1371/journal.pone.0203687. eCollection 2018. PLoS One. 2018. PMID: 30208076 Free PMC article.
-
Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease.Mol Neurodegener. 2019 Jan 11;14(1):3. doi: 10.1186/s13024-018-0304-2. Mol Neurodegener. 2019. PMID: 30634989 Free PMC article. Review.
-
Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues.Neuroimage. 2011 Feb 14;54(4):2899-914. doi: 10.1016/j.neuroimage.2010.10.025. Epub 2010 Oct 20. Neuroimage. 2011. PMID: 20969965 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical